Buy Medetomidine (Zenalpha) Cas 86347-14-0
Medetomidine/vatinoxan, sold under the brand name Zenalpha, is a veterinary fixed-dose combination medication used as a sedative and analgesic for dogs.[1][3] It contains medetomidine, an alpha2-adrenoceptor agonist, as the hydrochloride salt; and vatinoxan, an alpha2-adrenoceptor antagonist, as the hydrochloride salt.[2][3]
It was approved for veterinary use in the United States in May 2022,[3] and in Canada in May 2023.[1]
Veterinary use
Medetomidine/vatinoxan is indicated for use as a sedative and analgesic in dogs to facilitate clinical examination, clinical procedures and minor surgical procedures.[3]
Medetomidine/vatinoxan is used for sedation of dogs. It is only approved for standalone use.[5] A manufacturer trial found medetomidine/vatinoxan to have a faster onset and shorter duration of sedation with less respiratory depression and cardiovascular side effects as compared to medetomidine in dogs.[5]
Reviews
There are no reviews yet.